We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
(+9.5%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$516M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$253M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$210M |
| 4 |
Broadcom
AVGO
|
+$161M |
| 5 |
Uber
UBER
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$340M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$328M |
| 3 |
VMW
VMware, Inc
VMW
|
+$255M |
| 4 |
Chevron
CVX
|
+$187M |
| 5 |
lululemon athletica
LULU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.57% |
| 2 | Healthcare | 16.39% |
| 3 | Financials | 11.55% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Idexx Laboratories
IDXX
$46.1B
| $39.2M | 0.08% |
70,701
-38,055
| -35% | -$17.9M |
|
|
MRTX
252
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $39.2M | 0.08% |
667,424
-507,576
| -43% | -$28.5M |
|
|
BNY
253
Bank of New York Mellon
BNY
$108B
| $38.9M | 0.08% |
747,016
-27,300
| -4% | -$1.26M |
|
254
Monster Beverage
MNST
$91.1B
| $38.7M | 0.08% |
672,522
+148,300
| +28% | +$7.93M |
|
255
Viper Energy
VNOM
$14.9B
| $38.5M | 0.08% |
+1,226,600
| New | +$36.4M |
|
256
Carlisle Companies
CSL
$15.4B
| $38.1M | 0.08% |
122,000
+37,000
| +44% | +$10.2M |
|
257
Hayward Holdings
HAYW
$3.35B
| $38M | 0.08% |
2,791,075
-173,925
| -6% | -$2.14M |
|
258
Aura Biosciences
AURA
$752M
| $37.4M | 0.08% |
4,225,000
+1,350,000
| +47% | +$11.4M |
|
259
Archer Daniels Midland
ADM
$37.3B
| $37.4M | 0.08% |
518,092
-14,900
| -3% | -$1.09M |
|
260
Dow Inc
DOW
$22.1B
| $37.4M | 0.08% |
681,300
-17,700
| -3% | -$904K |
|
261
Ameriprise Financial
AMP
$49.3B
| $37.3M | 0.08% |
98,268
-3,800
| -4% | -$1.3M |
|
262
Darden Restaurants
DRI
$23.7B
| $37.2M | 0.08% |
226,354
+159,550
| +239% | +$24.2M |
|
263
Hilton Worldwide
HLT
$72.7B
| $37.2M | 0.08% |
204,100
+153,798
| +306% | +$25.1M |
|
264
MeiraGTx Holdings
MGTX
$1.17B
| $37.1M | 0.08% |
5,291,618
+620,601
| +13% | +$3.07M |
|
|
WBA
265
DELISTED
Walgreens Boots Alliance
WBA
| $37.1M | 0.08% |
1,419,845
+1,231,463
| +654% | +$27.5M |
|
266
Legend Biotech
LEGN
$3.72B
| $37M | 0.08% |
615,000
-1,093,510
| -64% | -$69.3M |
|
267
Cognizant
CTSH
$25.3B
| $36.8M | 0.08% |
487,050
-15,100
| -3% | -$1.04M |
|
268
Colgate-Palmolive
CL
$73.9B
| $36.7M | 0.08% |
460,420
-394,533
| -46% | -$29.7M |
|
269
Simon Property Group
SPG
$72.2B
| $36.6M | 0.08% |
256,863
+41,600
| +19% | +$5.03M |
|
270
TransDigm Group
TDG
$69.4B
| $36.6M | 0.08% |
36,194
-15,700
| -30% | -$14.5M |
|
271
Charles River Laboratories
CRL
$12.4B
| $36.4M | 0.08% |
154,055
+44,342
| +40% | +$8.72M |
|
272
TSMC
TSM
$2.18T
| $36.4M | 0.08% |
350,000
+75,000
| +27% | +$7.15M |
|
273
Fortinet
FTNT
$116B
| $36.2M | 0.08% |
619,090
-29,000
| -4% | -$1.6M |
|
274
Copart
CPRT
$26.6B
| $36.2M | 0.07% |
738,730
-5,170
| -0.7% | -$244K |
|
275
Savara
SVRA
$1.17B
| $35.9M | 0.07% |
7,637,930
-300,621
| -4% | -$1.15M |
|
Similar funds
Adage Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
- Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
- Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
- Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
- Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
- Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
- Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.
Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.